UPMC Hillman Cancer Center: Clinical Trials & Research Profile
Hospital / Clinical Site in Pittsburgh, PA · Primary Specialty: Oncology and Hematology
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Clinical Trial Research Site |
| Institutional Sector & Location | Hospital / Clinical Site (Pittsburgh, PA) |
| Primary Therapeutic Area | Oncology and Hematology |
| Active Phase II & III Studies | 205 active (108 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 282 |
| Completed vs Early-Stopped Studies | 28 completed / 39 stopped (13.8% stop rate) |
| Median Closed Enrollment | 45 participants |
| Median Completed Study Duration | 1,681 calendar days |
| Physical Hospital Site Disclosure | 100.0% named hospital campus |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for UPMC across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk